<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Turk J Haematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Turk J Haematol</journal-id>
      <journal-id journal-id-type="publisher-id">TJH</journal-id>
      <journal-title-group>
        <journal-title>Turkish Journal of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1300-7777</issn>
      <issn pub-type="epub">1308-5263</issn>
      <publisher>
        <publisher-name>Galenos Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26316488</article-id>
      <article-id pub-id-type="pmc">4451488</article-id>
      <article-id pub-id-type="doi">10.4274/tjh.2014.0034</article-id>
      <article-id pub-id-type="publisher-id">1459</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features</article-title>
        <trans-title-group xml:lang="tr">
          <trans-title>&#x130;ki Juvenil Myelomonositik L&#xF6;semili Hastan&#x131;n Klinik ve Genetik Bulgulara G&#xF6;re Tedavisi </trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>T&#xFC;fek&#xE7;i</surname>
            <given-names>&#xD6;zlem</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#xD6;ren</surname>
            <given-names>Hale</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yenig&#xFC;rb&#xFC;z</surname>
            <given-names>Fatma Demir</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>G&#xF6;zmen</surname>
            <given-names>Salih</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Karap&#x131;nar</surname>
            <given-names>Tuba Hilkay</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#x130;rken</surname>
            <given-names>G&#xFC;lersu</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>
Dokuz Eyl&#xFC;l University Faculty of Medicine, Department of Pediatric Hematology, &#x130;zmir, Turkey
</aff>
      <author-notes>
        <corresp id="COR1">* Address for Correspondence: Dokuz Eyl&#xFC;l University Faculty of Medicine, Department of Pediatric Hematology, &#x130;zmir, Turkey Phone: +90 232 412 61 41 E-mail: <email>hale.oren@deu.edu.tr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <volume>32</volume>
      <issue>2</issue>
      <fpage>175</fpage>
      <lpage>179</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>5</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Turkish Journal of Hematology, Published by Galenos Publishing.&#xD;
</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Juvenile myelomonocytic leukemia (JMML) is a rare clonal myeloproliferative disorder of childhood. Major progress has been achieved in diagnosis and the understanding of the pathogenesis of JMML by identifying the genetic pathologies that occur in patients. Mutations of RAS, NF1, PTPN11, and CBL are found in approximately 80% of JMML patients. Distinct clinical features have been reported to be associated with specific gene mutations. The advent of genomic studies and recent identification of novel genetic mutations in JMML are important not only in diagnosis but also in the management and prognosis of the disease. Herein, we present 2 patients with JMML harboring different mutations, NRAS and c-CBL, respectively, with distinct clinical features and different therapeutic approaches.</p>
      </abstract>
      <trans-abstract xml:lang="tr">
        <p>Juvenil myelomonositik l&#xF6;semi (JMML) &#xE7;ocukluk &#xE7;a&#x11F;&#x131;nda nadir g&#xF6;r&#xFC;len klonal myeloproliferatif bir hastal&#x131;kt&#x131;r. Hastalarda genetik patolojiler saptand&#x131;k&#xE7;a JMML&#x2019;nin tan&#x131; ve patogenezini anlamada &#xF6;nemli ilerlemeler kaydedilmi&#x15F;tir. Bu hastalar&#x131;n yakla&#x15F;&#x131;k %80&#x2019;inde RAS, NF1, PTPN11 ve CBL gen mutasyonlar&#x131; bulunmu&#x15F;tur. Belirli klinik bulgular ile spesifik gen mutasyonlar&#x131; aras&#x131;nda ili&#x15F;ki oldu&#x11F;u bildirilmektedir. JMML&#x2019;de genomik &#xE7;al&#x131;&#x15F;malardaki geli&#x15F;meler ve son y&#x131;llarda tan&#x131;mlanm&#x131;&#x15F; yeni genetik mutasyonlar&#x131;n saptanmas&#x131; sadece hastal&#x131;&#x11F;&#x131;n tan&#x131;s&#x131; i&#xE7;in de&#x11F;il, tedavi ve prognozunda da &#xF6;nem ta&#x15F;&#x131;maktad&#x131;r. Burada NRAS ve c-CBL mutasyonlar&#x131; olan iki JMML&#x2019;li hasta, belirli klinik bulgular&#x131; ve farkl&#x131; tedavi yakla&#x15F;&#x131;mlar&#x131; ile sunulmaktad&#x131;r.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>c-CBL mutation</kwd>
        <kwd>childhood</kwd>
        <kwd>Juvenile myelomonocytic leukemia</kwd>
        <kwd>NRAS mutation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>INTRODUCTION</title>
      <p>Juvenile myelomonocytic leukemia (JMML) is a rare clonal myeloproliferative disorder that accounts for 2%-3% of all pediatric leukemias [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref5" ref-type="bibr">5</xref>]. Clinically, patients generally present with pallor, fever, lymphadenopathy, and splenomegaly. Leukocytosis with monocytosis, circulating myeloid/erythroid precursors, varying degrees of myelodysplasia, and thrombocytopenia are common findings found in peripheral blood [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref7" ref-type="bibr">7</xref>]. Hypersensitivity of hematopoietic progenitors to granulocyte-macrophage colony-stimulating factor is characteristic of JMML [<xref rid="ref8" ref-type="bibr">8</xref>]. </p>
      <p>Major progress has been achieved in diagnosis and the understanding of the pathogenesis of JMML by identifying the genetic pathologies that occur in patients. Mutations of RAS, NF1, PTPN11, and CBL, the genes involved in the RAS-MAPK pathway, are found in approximately 80% of these patients [<xref rid="ref9" ref-type="bibr">9</xref>]. The advent of genomic studies and recent identification of novel genetic mutations in JMML are important not only in diagnosis but also in phenotypic presentation, prognosis, and clinical management of the disease [<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref11" ref-type="bibr">11</xref>,<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref13" ref-type="bibr">13</xref>,<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref16" ref-type="bibr">16</xref>]. </p>
      <p>In the past, the only known curative therapy for JMML was hematopoietic stem cell transplantation (HSCT), but recently it was reported that some patients have clinical improvement and long-term survival without any treatment [<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref16" ref-type="bibr">16</xref>]. Herein, we present 2 patients with JMML harboring different mutations, NRAS and c-CBL, respectively, with distinct clinical features and different clinical courses. Informed consent was obtained.</p>
    </sec>
    <sec id="s2">
      <title>CASE PRESENTATION</title>
      <sec id="s2a">
        <title>Patient 1</title>
        <p>A 9-month-old male was admitted with complaints of fever, bloody diarrhea, and recurrent lower respiratory tract infections of 3 months in duration. His physical examination was normal. The complete blood count analysis was as follows: hemoglobin of 9.4 g/dL, white blood cells of 39.7x109/L (with neutrophil predominance), and platelets of 185x109/L. Immunological and serological testing excluded immunodeficiency and viral infections. Bone marrow aspiration showed myeloid lineage predominance with slight dysmyelopoiesis. Cytogenetic analysis of the bone marrow sample revealed a normal karyotype and a negative result for the BCR/ABL fusion gene. During follow-up, he began to suffer from diarrhea, febrile episodes, and painful vasculitic skin lesions with no infectious origin. Mild thrombocytopenia, monocytosis, and myeloid precursors on peripheral blood smear appeared 6 months after his first admission. Analysis of hemoglobin electrophoresis revealed increased hemoglobin F (23%). Diagnosis of JMML was made according to the current WHO diagnostic criteria [<xref rid="ref17" ref-type="bibr">17</xref>]. The genetic work-up from the peripheral blood sample revealed somatic heterozygous mutation in NRAS exon 2 p61 Q&gt;P and a donor search for HSCT was started immediately after diagnosis. A cytoreductive treatment with 6-mercaptopurine and low-dose cytosine arabinoside was started. Prednisolone at a dose of 2 mg/kg per day was started with possible accompanying autoimmune, autoinflammatory characteristics of the disease. After the 15th day of steroid treatment, his fever, cutaneous lesions, and diarrhea attacks subsided. During follow-up, 6-mercaptopurine, low-dose cytosine arabinoside, and steroids were administered from time to time depending on his clinical features. As soon as a fully matched unrelated donor was found, allogeneic HSCT was performed. He has been in remission for 7 months.</p>
      </sec>
      <sec id="s2b">
        <title>Patient 2</title>
        <p>A 17-month-old female presented with fever, failure to thrive, and recurrent respiratory tract infections of a few months in duration. She was 71 cm tall (&lt;3rd percentile), weighed 7.5 kg (&lt;3rd percentile), and had an occipitofrontal head circumference of 43 cm (&lt;3rd percentile). Physical examination revealed broad forehead, mild hypertelorism, short upturned nose, prominent philtrum, mild retrognathism, pallor, petechiae, hepatomegaly (3 cm below the costal margin), and splenomegaly (8 cm below the costal margin). The complete blood count analysis showed leukocytosis (53.7x109/L), monocytosis (11.1x109/L), anemia (Hb: 8.9 g/dL), and thrombocytopenia (platelets: 46x109/L). Peripheral blood smear showed a leukoerythroblastic picture, dysplastic monocytes, and monocytosis (23%). Bone marrow examination revealed cellular smears with myeloid hyperplasia, features of dysmyelopoiesis, and presence of 3% blasts. Cytogenetic studies of the patient revealed a normal karyotype with absence of the BCR/ABL fusion gene, monosomy 7, or any other chromosomal abnormality. Hemoglobin F level was 3%. JMML was diagnosed according to the WHO criteria [<xref rid="ref17" ref-type="bibr">17</xref>]. Genetic analysis of the peripheral blood samples revealed heterozygous germline mutation in c-CBL exon 8 p371 Y&gt;H. The same genetic mutation was detected in DNA isolated from the hair follicles, indicating the germline origin of the mutation. Her diagnosis was consistent with the CBL syndrome. The family members were negative for c-CBL mutation. Cytoreductive therapy with 6-mercaptopurine (50 mg/m2 per day, given orally) was started and has continued to date. The hepatosplenomegaly decreased in size and leukocytosis regressed. The disease has been stable for 2 years.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>DISCUSSION AND REVIEW OF THE LITERATURE</title>
      <p>JMML is clinically a heterogeneous disease [<xref rid="ref6" ref-type="bibr">6</xref>]. Although most patients experience an aggressive clinical course and die if not treated with HSCT, there are some patients with better clinical course and spontaneous improvement [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref16" ref-type="bibr">16</xref>]. Classically, young age at diagnosis (&lt;2 years), platelet counts above 33x109/L, and hemoglobin F of less than 15% at diagnosis have been identified as favorable prognostic factors [<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref18" ref-type="bibr">18</xref>]. In addition to these known prognostic factors, increased molecular knowledge of the molecular pathogenesis of JMML has made it possible to outline clinical characteristics and prognosis of the disease for some mutation types [<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref11" ref-type="bibr">11</xref>,<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref13" ref-type="bibr">13</xref>,<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref16" ref-type="bibr">16</xref>]. </p>
      <p>Patient 1 was found to have NRAS mutation. RAS proteins are small GTP-binding signaling molecules that control cell proliferation, survival, and differentiation [<xref rid="ref19" ref-type="bibr">19</xref>]. The activation of RAS is an essential step in the proliferation of cells for most hematopoietic growth factors [<xref rid="ref20" ref-type="bibr">20</xref>]. Somatic activating point mutations of NRAS or KRAS genes are found in 20%-30% of patients with JMML [<xref rid="ref6" ref-type="bibr">6</xref>]. Flotho et al. [<xref rid="ref21" ref-type="bibr">21</xref>] reviewed the clinical and molecular data of 216 cases collected by the EWOG-MDS group and recommended prompt HSCT for every patient with JMML, except children with Noonan syndrome. There are some studies that reported lower relapse rates and better event-free survival with RAS mutations [<xref rid="ref22" ref-type="bibr">22</xref>,<xref rid="ref23" ref-type="bibr">23</xref>]. RAS mutations have been reported to be associated with autoimmune phenomena [<xref rid="ref11" ref-type="bibr">11</xref>,<xref rid="ref24" ref-type="bibr">24</xref>,<xref rid="ref25" ref-type="bibr">25</xref>]. Oliveira et al. [<xref rid="ref24" ref-type="bibr">24</xref>] reported that NRAS has an immune regulatory function. The clinical syndrome of autoimmune phenomena, lymphocyte accumulation, and somatic mutations in NRAS, previously designated as ALPS type IV, is now reclassified as a new nosologic entity termed RALD, for RAS-associated autoimmune leukoproliferative disease [<xref rid="ref25" ref-type="bibr">25</xref>,<xref rid="ref26" ref-type="bibr">26</xref>]. </p>
      <p>Mutations causing alteration in the structure of CBL protein have recently been associated with various myeloid malignancies, including JMML [<xref rid="ref13" ref-type="bibr">13</xref>,<xref rid="ref27" ref-type="bibr">27</xref>,<xref rid="ref28" ref-type="bibr">28</xref>]. Patient 2 was found to have marked growth retardation, some phenotypic features, and germline c-CBL mutation. Mutation in c-CBL exon 8 p371 Y&gt;H is the most commonly encountered mutation detected in CBL syndrome [<xref rid="ref13" ref-type="bibr">13</xref>,<xref rid="ref14" ref-type="bibr">14</xref>]. Niemeyer et al. [<xref rid="ref13" ref-type="bibr">13</xref>] reported that the common p371 Y&gt;H mutation causing alteration in CBL protein induces cytokine-independent growth and constitutive phosphorylation only in hematopoietic cells. There are limited reports in the literature about CBL syndrome, but it is important to note that most of these studies have documented the spontaneous resolution rate of JMML in this group of patients [<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref16" ref-type="bibr">16</xref>]. On the other hand, these patients with CBL syndrome have also been reported to develop serious vasculopathies later in life as evidenced by optic atrophy, hypertension, cardiomyopathy, or arteritis [<xref rid="ref14" ref-type="bibr">14</xref>]. As our patient harbored germline c-CBL mutation and had a chance of spontaneous resolution, HSCT was not planned as an initial treatment. </p>
      <p>In conclusion, JMML is phenotypically and genotypically a heterogeneous disease. Despite the aggressive clinical course observed in most patients, some patients may have a mild clinical course. Recent developments in identifying molecular lesions have revealed the importance of genotype-phenotype correlation in this disease, which is critical for tailoring the management. Every patient with a possible diagnosis of JMML should be screened for underlying molecular lesions. </p>
    </sec>
  </body>
  <back>
    <ack>
      <p>
        <bold>Acknowledgment</bold>
      </p>
      <p>We are grateful to Prof. Dr. Charlotte M. Niemeyer, Dr. Mutlu Kartal-Kaess, and Dr. Annamaria Cseh for performing genetic analysis in the Division of Pediatric Hematology and Oncology and Department of Pediatrics and Adolescent Medicine, University Clinic of Freiburg, Germany, and for their contributions in the diagnosis and management of the patients. </p>
    </ack>
    <fn-group>
      <fn id="FN1" fn-type="conflict">
        <p>
          <bold>Conflict of Interest Statement</bold>
        </p>
        <p>The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Niemeyer</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kratz</surname>
              <given-names>CP</given-names>
            </name>
          </person-group>
          <article-title>Pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: molecular classification and treatment options</article-title>
          <source>Br J Hematol</source>
          <year>2008</year>
          <volume>140</volume>
          <fpage>610</fpage>
          <lpage>624</lpage>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Locatelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>N&#xF6;llke</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zecca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Korthof</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lanino</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pession</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kabisch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Uderzo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bonfim</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Bader</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dilloo</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stary</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Revesz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>F&#xFC;hrer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hasle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Trebo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fenu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Strahm</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Giorgiani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bonora</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Duffner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>105</volume>
          <fpage>410</fpage>
          <lpage>419</lpage>
          <pub-id pub-id-type="pmid">15353481</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Niemeyer</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Arico</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Basso</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Biondi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cantu Rajnoldi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Creutzig</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Harbott</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hasle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kerndrup</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stollmann-Gibbels</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>van&#x2019;t Veer-Korthof</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Wering</surname>
              <given-names>E</given-names>
              <suffix>van</suffix>
            </name>
            <name>
              <surname>Zimmermann</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases</article-title>
          <source>European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood</source>
          <year>1997</year>
          <volume>89</volume>
          <fpage>3534</fpage>
          <lpage>3543</lpage>
          <pub-id pub-id-type="pmid">9160658</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Luna-Fineman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shannon</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Atwater</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Masterson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ortega</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sanders</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Steinherz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients</article-title>
          <source>Blood</source>
          <year>1999</year>
          <volume>93</volume>
          <fpage>459</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="pmid">9885207</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Sasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Manabe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tsuchida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ikuta</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Okamura</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ishii</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Komada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hibi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan</article-title>
          <source>Leukemia</source>
          <year>2001</year>
          <volume>15</volume>
          <fpage>1713</fpage>
          <lpage>1720</lpage>
          <pub-id pub-id-type="pmid">11681412</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshimi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations</article-title>
          <source>Paediatr Drugs</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>11</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">20034338</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Loh</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia</article-title>
          <source>Br J Haematol</source>
          <year>2011</year>
          <volume>152</volume>
          <fpage>677</fpage>
          <lpage>687</lpage>
          <pub-id pub-id-type="pmid">21623760</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Emanuel</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Bates</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Castleberry</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Gualtieri</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Zuckerman</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</article-title>
          <source>Blood</source>
          <year>1991</year>
          <volume>77</volume>
          <fpage>925</fpage>
          <lpage>929</lpage>
          <pub-id pub-id-type="pmid">1704804</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Loh</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Mullighan</surname>
              <given-names>CG</given-names>
            </name>
          </person-group>
          <article-title>Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy</article-title>
          <source>Clin Cancer Res</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>2754</fpage>
          <lpage>2767</lpage>
          <pub-id pub-id-type="pmid">22589484</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Doisaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Current management of juvenile myelomonocytic leukemia and the impact of RAS mutations</article-title>
          <source>Paediatr Drugs</source>
          <year>2012</year>
          <volume>14</volume>
          <fpage>157</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">22480363</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Takagi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shinoda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Piao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mitsuiki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Muramatsu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Doisaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nagasawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morio</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kasahara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takao</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mizutani</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation</article-title>
          <source>Blood</source>
          <year>2011</year>
          <volume>117</volume>
          <fpage>2887</fpage>
          <lpage>2890</lpage>
          <pub-id pub-id-type="pmid">21063026</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yajima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iizuka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yanai</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kawasaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yanagimachi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kikuchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ohtsuka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hidaka</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Yamauchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yanagisawa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nakazawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shiohara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Manabe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations</article-title>
          <source>Blood</source>
          <year>2007</year>
          <volume>109</volume>
          <fpage>5477</fpage>
          <lpage>5480</lpage>
          <pub-id pub-id-type="pmid">17332249</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Loh</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Flotho</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fliegauf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Archambeault</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mullighan</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bergstraesser</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bueso-Ramos</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Emanuel</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Hasle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Issa</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Stary</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Trebo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wlodarski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zecca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shannon</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Niemeyer</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Mutations in CBL occur frequently in juvenile myelomonocytic leukemia</article-title>
          <source>Blood</source>
          <year>2009</year>
          <volume>114</volume>
          <fpage>1859</fpage>
          <lpage>1863</lpage>
          <pub-id pub-id-type="pmid">19571318</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Niemeyer</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Furlan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Erlacher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bunin</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Bunda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Finklestein</surname>
              <given-names>JZ</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Gorr</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kropshofer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Corbacioglu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schlegel</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Heinzmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Star&#xFD;</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hasle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Archambeault</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Sybingco</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Ohh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Flotho</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Loh</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia</article-title>
          <source>Nat Genet</source>
          <year>2010</year>
          <volume>42</volume>
          <fpage>794</fpage>
          <lpage>800</lpage>
          <pub-id pub-id-type="pmid">20694012</pub-id>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mechinaud</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Galambrun</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ben Romdhane</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Isidor</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Philip</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Derain-Court</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cassinat</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lachenaud</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kaltenbach</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Salmon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>D&#xE9;sir&#xE9;e</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Menot</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Royer</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fenneteau</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Baruchel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chomienne</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Verloes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cav&#xE9;</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia</article-title>
          <source>J Med Genet</source>
          <year>2010</year>
          <volume>47</volume>
          <fpage>686</fpage>
          <lpage>691</lpage>
          <pub-id pub-id-type="pmid">20543203</pub-id>
        </element-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taira</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sakashita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanaka-Yanagisawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yanagisawa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nakazawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shiohara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakahata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations</article-title>
          <source>Blood</source>
          <year>2010</year>
          <volume>115</volume>
          <fpage>5429</fpage>
          <lpage>5431</lpage>
          <pub-id pub-id-type="pmid">20595524</pub-id>
        </element-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kratz</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Loh</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium</article-title>
          <source>Leuk Res</source>
          <year>2009</year>
          <volume>33</volume>
          <fpage>355</fpage>
          <lpage>362</lpage>
          <pub-id pub-id-type="pmid">18954903</pub-id>
        </element-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Passmore</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Chessells</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Kempski</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hann</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Brownbill</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Stiller</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival</article-title>
          <source>Br J Haematol</source>
          <year>2003</year>
          <volume>121</volume>
          <fpage>758</fpage>
          <lpage>767</lpage>
          <pub-id pub-id-type="pmid">12780790</pub-id>
        </element-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Malumbres</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barbacid</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>RAS oncogenes: the first 30 years</article-title>
          <source>Nat Rev Cancer</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>459</fpage>
          <lpage>465</lpage>
          <pub-id pub-id-type="pmid">12778136</pub-id>
        </element-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakafuku</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miyajima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kaziro</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/ macrophage colony-stimulating factor, but not from interleukin 4</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1991</year>
          <volume>88</volume>
          <fpage>3314</fpage>
          <lpage>3318</lpage>
          <pub-id pub-id-type="pmid">1826565</pub-id>
        </element-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Flotho</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kratz</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Bergstr&#xE4;sser</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hasle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stary</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Trebo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wojcik</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zecca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Niemeyer</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <collab>European Working Group of Myelodysplastic Syndromes in Childhood</collab>
          <article-title>Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations</article-title>
          <source>Blood</source>
          <year>2008</year>
          <volume>111</volume>
          <fpage>966</fpage>
          <lpage>967</lpage>
          <pub-id pub-id-type="pmid">18182584</pub-id>
        </element-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yagasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yoshimi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nishio</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Muramatsu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ueyama</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Inada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yabe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kudo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mimaya</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kikuchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Manabe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia</article-title>
          <source>Pediatr Res</source>
          <year>2009</year>
          <volume>65</volume>
          <fpage>334</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">19047918</pub-id>
        </element-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Bresolin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zecca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Flotho</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Trentin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zangrando</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sainati</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Stary</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Moerloose</surname>
              <given-names>B</given-names>
              <suffix>de</suffix>
            </name>
            <name>
              <surname>Hasle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Niemeyer</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Te Kronnie</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Basso</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia</article-title>
          <source>J Clin Oncol</source>
          <year>2010</year>
          <volume>28</volume>
          <fpage>1919</fpage>
          <lpage>1927</lpage>
          <pub-id pub-id-type="pmid">20231685</pub-id>
        </element-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Bidere</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Niemela</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nix</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Danner</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Barb</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Munson</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Puck</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dale</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Straus</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Fleisher</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Lenardo</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>NRAS mutation causes a human autoimmune lymphoproliferative syndrome</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>8953</fpage>
          <lpage>8958</lpage>
          <pub-id pub-id-type="pmid">17517660</pub-id>
        </element-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Niemela</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fleisher</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Caminha</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Natter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Beer</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Dowdell</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Pittaluga</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Raffeld</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis</article-title>
          <source>Blood</source>
          <year>2011</year>
          <volume>117</volume>
          <fpage>2883</fpage>
          <lpage>2886</lpage>
          <pub-id pub-id-type="pmid">21079152</pub-id>
        </element-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Bleesing</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Dianzani</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Fleisher</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Lenardo</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Rieux-Laucat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Teachey</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>VK</given-names>
            </name>
          </person-group>
          <article-title>Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop</article-title>
          <source>Blood</source>
          <year>2010</year>
          <volume>116</volume>
          <fpage>e35</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">20538792</pub-id>
        </element-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Dikic</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>The Cbl interactome and its functions</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>907</fpage>
          <lpage>918</lpage>
          <pub-id pub-id-type="pmid">16227975</pub-id>
        </element-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Caligiuri</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Briesewitz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fleisher</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Lenardo</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Rieux-Laucat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Teachey</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>VK</given-names>
            </name>
          </person-group>
          <article-title>Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia</article-title>
          <source>Blood</source>
          <year>2007</year>
          <volume>110</volume>
          <fpage>1022</fpage>
          <lpage>1024</lpage>
          <pub-id pub-id-type="pmid">17475912</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
